1. Home
  2. NSPR vs TIMB Comparison

NSPR vs TIMB Comparison

Compare NSPR & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • TIMB
  • Stock Information
  • Founded
  • NSPR 2005
  • TIMB 1998
  • Country
  • NSPR United States
  • TIMB Brazil
  • Employees
  • NSPR N/A
  • TIMB N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • TIMB Telecommunications Equipment
  • Sector
  • NSPR Health Care
  • TIMB Telecommunications
  • Exchange
  • NSPR Nasdaq
  • TIMB Nasdaq
  • Market Cap
  • NSPR 99.7M
  • TIMB 94.1M
  • IPO Year
  • NSPR N/A
  • TIMB 1998
  • Fundamental
  • Price
  • NSPR $2.35
  • TIMB $22.14
  • Analyst Decision
  • NSPR Strong Buy
  • TIMB Hold
  • Analyst Count
  • NSPR 2
  • TIMB 4
  • Target Price
  • NSPR $4.50
  • TIMB $20.50
  • AVG Volume (30 Days)
  • NSPR 135.7K
  • TIMB 236.8K
  • Earning Date
  • NSPR 11-11-2025
  • TIMB 11-04-2025
  • Dividend Yield
  • NSPR N/A
  • TIMB 6.39%
  • EPS Growth
  • NSPR N/A
  • TIMB 16.41
  • EPS
  • NSPR N/A
  • TIMB 0.27
  • Revenue
  • NSPR $7,066,000.00
  • TIMB $4,779,664,328.00
  • Revenue This Year
  • NSPR $7.48
  • TIMB $8.08
  • Revenue Next Year
  • NSPR $104.39
  • TIMB $5.29
  • P/E Ratio
  • NSPR N/A
  • TIMB $15.84
  • Revenue Growth
  • NSPR 7.60
  • TIMB 5.32
  • 52 Week Low
  • NSPR $1.99
  • TIMB $11.32
  • 52 Week High
  • NSPR $3.80
  • TIMB $22.47
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 42.67
  • TIMB 60.33
  • Support Level
  • NSPR $2.30
  • TIMB $20.41
  • Resistance Level
  • NSPR $2.50
  • TIMB $22.29
  • Average True Range (ATR)
  • NSPR 0.09
  • TIMB 0.40
  • MACD
  • NSPR -0.01
  • TIMB 0.00
  • Stochastic Oscillator
  • NSPR 16.98
  • TIMB 90.10

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About TIMB TIM S.A. (Each representing 5)

TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.

Share on Social Networks: